AusPAR: Tofacitinib (as citrate)

Australian Public Assessment Report

AusPAR

AusPAR: Tofacitinib (as citrate) [PDF, 915.88 KB]

AusPAR: Tofacitinib (as citrate) [Word, 2.01 MB]

Attachment: Product Information: Tofacitinib (as citrate) [PDF, 451.56 KB]

Attachment: Product Information: Tofacitinib (as citrate) [Word, 450.37 KB]

Attachment: Extract from Clinical Evaluation Tofacitinib (as citrate) [PDF, 1.91 MB]

Attachment: Extract from Clinical Evaluation Tofacitinib (as citrate) [Word, 4.05 MB]

Device/Product Name

Xeljanz

Active ingredients

Tofacitinib (as citrate)

AusPAR Date

25 May 2018

Published

10 July 2018

Submission Number

PM-2016-00757-1-3

Submission Type

Extension of indications

Decision

Approved